| NDC Code | 62037-726-01 |
|---|
| Package Description | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (62037-726-01) |
|---|
| Product NDC | 62037-726 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Methylphenidate Hydrochloride |
|---|
| Non-Proprietary Name | Methylphenidate Hydrochloride |
|---|
| Dosage Form | TABLET, FILM COATED, EXTENDED RELEASE |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20190304 |
|---|
| Marketing Category Name | ANDA |
|---|
| Application Number | ANDA076772 |
|---|
| Manufacturer | Actavis Pharma, Inc. |
|---|
| Substance Name | METHYLPHENIDATE HYDROCHLORIDE |
|---|
| Strength | 36 |
|---|
| Strength Unit | mg/1 |
|---|
| Pharmacy Classes | Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE] |
|---|
| DEA Schedule | CII |
|---|